PLA2G7 and coronary artery disorder: According to Adult Treatment Panel-III (ATP-III) guidelines, measuring the Lp-PLA2 levels is useful for a more accurate diagnosis of coronary heart disease (CHD) risk [5], especially in patients with low-density lipoprotein (LDL) less than 130 mg/dl [6].